These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 19031945

  • 21. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].
    Zhang J, Li YH, Cui AR, Wang JL, Cheng JX, Wang SJ.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990
    [Abstract] [Full Text] [Related]

  • 22. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
    Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, Quddus MR, Lawrence WD.
    Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
    Solomon LA, Munkarah AR, Schimp VL, Arabi MH, Morris RT, Nassar H, Ali-Fehmi R.
    Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of laminin-5 in serous adenocarcinomas of the ovary.
    Kohlberger P, Muller-Klingspor V, Heinzl H, Obermair A, Breitenecker G, Leodolter S.
    Anticancer Res; 2002 Jun; 22(6B):3541-4. PubMed ID: 12552953
    [Abstract] [Full Text] [Related]

  • 26. B7-H4 overexpression in ovarian tumors.
    Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas.
    Zhang X, Wang X, Song X, Wei Z, Zhou C, Zhu F, Wang Q, Ma C, Zhang L.
    Oncol Rep; 2011 Feb; 25(2):353-8. PubMed ID: 21165576
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK, Chao TK, Yu CP, Yu MH, Jin JS.
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.
    Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A.
    Gynecol Oncol; 2005 Feb; 96(2):355-61. PubMed ID: 15661221
    [Abstract] [Full Text] [Related]

  • 33. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.
    Gamzatova Z, Villabona L, Dahlgren L, Dalianis T, Nillson B, Bergfeldt K, Masucci GV.
    Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ, Mhawech-Fauceglia P, Groth J, Lele S, Sood AK.
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [Abstract] [Full Text] [Related]

  • 36. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.
    Ali-Fehmi R, Morris RT, Bandyopadhyay S, Che M, Schimp V, Malone JM, Munkarah AR.
    Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
    Yakirevich E, Sabo E, Lavie O, Mazareb S, Spagnoli GC, Resnick MB.
    Clin Cancer Res; 2003 Dec 15; 9(17):6453-60. PubMed ID: 14695148
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
    Horiuchi A, Iinuma H, Akahane T, Shimada R, Watanabe T.
    Oncol Rep; 2012 May 15; 27(5):1384-92. PubMed ID: 22267128
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.